Replies to post #739 on Trius Therapeutics, Inc. (TSRX)

[TRUISM]

There's a lawsuit filed,stating that the value is closer to an analyst's pricing of $20 per share.

Makes me wonder even more if another company may appear in the midst of this confusion and make a bid.


Take Care and God Bless....God Bless Us All.


Truth4Once